The main purpose of this legislation is to change how coinsurance for prescription drugs under Medicare Part D is calculated. Currently, coinsurance is based on the wholesale acquisition cost of drugs, which can be higher than what the drugs actually cost. This bill aims to ensure that coinsurance is instead based on the actual acquisition cost, which reflects the negotiated price after any discounts or concessions from manufacturers.